Healthcare
3-D Matrix, Ltd.(DMTRF)
Live Price
Offline$2.25
+0.00% today
1Y Change
+226.09%
Window
Jun 25, 2025 โ Jun 17, 2026
- Market Cap
- $60.47B
- Revenue Growth
- +51.1%
- EPS Growth
- -622.1%
- Dividend Yield
- 0.0%
Coverage: 250 bars ยท Jun 25, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
3-D Matrix, Ltd. (DMTRF) is a Healthcare stock with a market cap of $60.47B and listed on OTC. The stock last traded around $2.25 and up 226.1% across the available one-year price window (Jun 25, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +51.1%, EPS growth of -622.1%, a dividend yield of 0.0%. What stands out right now is revenue +51.1%, EPS -622.1%, free cash flow +9.3% with operating margin 1.7% and ROIC 2.1%. Valuation already assumes a fairly strong business story at P/E 49.7 and price/sales 6.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines DMTRF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+51.1% vs +7.6% peer median
Operating Margin
Below sector median
+1.7% vs +19.4% peer median
P/E
Above sector median
49.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Jun 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +51.1% and EPS is at -622.1%, with operating margin around 1.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Jun 11, 2026 | โ | +0.0% | โ | โ |
2026 Mar 12, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Oct 31, 2025 | โ | +0.0% | +0.0% | +27.3% |
Benchmark Edge
DMTRF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DMTRF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DMTRF Max Drawdown
-43.18%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for DMTRF and SPY.
Company Overview
3-D Matrix, Ltd.
Other OTC
3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.
- Leadership
- Keiji Nagano
- IPO Date
- Jun 19, 2013
- Employees
- 106
- Street Address
- Kojimachi HF Building
- Mailing
- Tokyo, 102-0083
- Region
- Tokyo, JP
- Reporting Currency
- USD
- Investor Line
- 81 3 3511 3440
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 49.7
- EV/EBITDA
- 46.8
- Price/Sales
- 6.6
- Price/Book
- 11.9
Growth
- Revenue
- +51.1%
- EPS
- -622.1%
- Free Cash Flow
- +9.3%
Profitability
- Gross Margin
- 70.6%
- Operating Margin
- 1.7%
- Net Margin
- 13.5%
- ROE
- 35.5%
- ROIC
- 2.1%
Balance Sheet
- Debt/Equity
- 0.11
- Current Ratio
- 3.63
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.